Patent · US Active

Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions

US8663944B2 · kind B2 · utility

1Cited by

3References

2Claims

0Family size

Assignee

ANAMAR AB · SE

Inventors

Pilar Lorenzo · Lund, SE
Tore Saxne · Lund, SE
Dick Heineg{dot over (a)}rd · Lund, SE

Key dates

Filing date	Aug 17, 2010
Grant date	Mar 4, 2014
Priority date	—
Expiry date	Sep 17, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/105
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method for differentiation of osteoarthritis from rheumatoid arthritis and non-disease conditions in a sample, comprising measuring in the sample the concentration of human cartilage intermediate layer protein 2 (CILP-2) in body fluids and more specifically, measuring in the sample the concentration of the N-terminal part of CILP-2 (2C1) or fragments thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.